Atlas Brown’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
2,613
+13
+0.5% +$1.05K 0.05% 233
2026
Q1
$225K Buy
2,600
+374
+17% +$35.8K 0.07% 208
2025
Q4
$214K Buy
2,226
+19
+0.9% +$1.85K 0.06% 215
2025
Q3
$210K Sell
2,207
-164
-7% -$15.1K 0.06% 218
2025
Q2
$207K Sell
2,371
-15
-0.6% -$1.27K 0.07% 213
2025
Q1
$214K Buy
+2,386
New +$214K 0.08% 199
2024
Q4
Sell
-2,351
Closed -$212K 214
2024
Q3
$212K Sell
2,351
-1,040
-31% -$87.5K 0.07% 200
2024
Q2
$267K Buy
3,391
+19
+0.6% +$1.56K 0.1% 174
2024
Q1
$294K Buy
+3,372
New +$288K 0.11% 162
2022
Q2
Sell
-1,922
Closed -$213K 187
2022
Q1
$213K Buy
+1,922
New +$203K 0.09% 172
2021
Q4
Sell
-1,718
Closed -$215K 197
2021
Q3
$215K Sell
1,718
-41
-2% -$5.31K 0.09% 172
2021
Q2
$218K Buy
1,759
+1
+0.1% +$126 0.09% 170
2021
Q1
$208K Buy
1,758
+2
+0.1% +$234 0.1% 164
2020
Q4
$206K Sell
1,756
-498
-22% -$54.8K 0.11% 157
2020
Q3
$234K Buy
2,254
+2
+0.1% +$201 0.14% 139
2020
Q2
$207K Buy
+2,252
New +$216K 0.13% 143

Other funds holding MDT

Atlas Brown's MDT Position: Q2 2026 in Review

Atlas Brown increased its Medtronic (MDT) stake by 0.5% in Q2 2026, buying an estimated $1.05K and bringing the position to 2,613 shares worth $204K. The position accounts for 0.05% of the portfolio, ranked #233.

Atlas Brown first reported a position in MDT in Q2 2020 and has held it in 16 quarters since. The position peaked at $294K in Q1 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Atlas Brown held 2,613 shares of Medtronic worth $204K as of Q2 2026.
  • Atlas Brown bought 13 Medtronic shares in Q2 2026, an estimated $1.05K.
  • Medtronic made up 0.05% of Atlas Brown's portfolio in Q2 2026, its #233 holding.
  • Atlas Brown first reported a position in Medtronic in Q2 2020 and has held it in 16 quarters since.
  • Atlas Brown's Medtronic position peaked at $294K in Q1 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.